Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Horner

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Infectious Diseases|December 11, 2013
Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!Patrick Horner, Karla Blee, Elisabeth Adams
International Journal of STD & AIDS|February 11, 2017
Diagnosis of some genital-tract infections: part 1. An historical perspectiveDavid Taylor-Robinson, Anna Pallecaros, Patrick Horner
Medical Education|February 1, 2003
Teaching sexual history taking to medical students and examining it: experience in one medical school and a national surveyMark FitzGerald, Tessa Crowley, Peter Greenhouse, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a reviewFabian Yuh Shiong Kong, Patrick Horner, Magnus Unemo, et al.
Microbes and Infection|February 15, 2011
HIV-1 does not significantly influence Chlamydia trachomatis serovar L2 replication in vitroAndrew Broadbent, Patrick Horner, Gillian Wills, et al.
Sexually Transmitted Diseases|February 5, 2003
Antibodies to Chlamydia trachomatis heat-shock protein 60 kDa and detection of Mycoplasma genitalium and ureaplasma urealyticum are associated independently with chronic nongonococcal urethritisPatrick Horner, Brenda Thomas, Claire Gilroy, et al.
Sexually Transmitted Infections|July 19, 2017
Which azithromycin regimen should be used for treating <i>Mycoplasma genitalium</i>? A meta-analysisPatrick Horner, Suzanne M Ingle, Frederick Garrett, et al.
Sexually Transmitted Infections|November 26, 2013
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in EnglandKatherine M E Turner, Jeff Round, Patrick Horner, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2017
Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infectionsRachel Pitt, Sarah Alexander, Catherine Ison, et al.
Sexually Transmitted Diseases|February 3, 2021
Human Immunodeficiency Virus Preexposure Prophylaxis Knowledge, Attitudes and Perceptions of Sexual Health Risk in an Age of Sexually Transmitted Infection Antimicrobial ResistanceAva Lorenc, Jane Nicholls, Joanna May Kesten, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Infectious Diseases|December 11, 2013
Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!Patrick Horner, Karla Blee, Elisabeth Adams
International Journal of STD & AIDS|February 11, 2017
Diagnosis of some genital-tract infections: part 1. An historical perspectiveDavid Taylor-Robinson, Anna Pallecaros, Patrick Horner
Medical Education|February 1, 2003
Teaching sexual history taking to medical students and examining it: experience in one medical school and a national surveyMark FitzGerald, Tessa Crowley, Peter Greenhouse, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a reviewFabian Yuh Shiong Kong, Patrick Horner, Magnus Unemo, et al.
Microbes and Infection|February 15, 2011
HIV-1 does not significantly influence Chlamydia trachomatis serovar L2 replication in vitroAndrew Broadbent, Patrick Horner, Gillian Wills, et al.
Sexually Transmitted Diseases|February 5, 2003
Antibodies to Chlamydia trachomatis heat-shock protein 60 kDa and detection of Mycoplasma genitalium and ureaplasma urealyticum are associated independently with chronic nongonococcal urethritisPatrick Horner, Brenda Thomas, Claire Gilroy, et al.
Sexually Transmitted Infections|July 19, 2017
Which azithromycin regimen should be used for treating <i>Mycoplasma genitalium</i>? A meta-analysisPatrick Horner, Suzanne M Ingle, Frederick Garrett, et al.
Sexually Transmitted Infections|November 26, 2013
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in EnglandKatherine M E Turner, Jeff Round, Patrick Horner, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2017
Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infectionsRachel Pitt, Sarah Alexander, Catherine Ison, et al.
Sexually Transmitted Diseases|February 3, 2021
Human Immunodeficiency Virus Preexposure Prophylaxis Knowledge, Attitudes and Perceptions of Sexual Health Risk in an Age of Sexually Transmitted Infection Antimicrobial ResistanceAva Lorenc, Jane Nicholls, Joanna May Kesten, et al.
Pageof 2